Detalhe da pesquisa
1.
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
Blood
; 120(9): 1801-9, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22665938
2.
Clinical problem-solving. Diagnosing one letter at a time.
N Engl J Med
; 372(1): 67-73, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25551528
3.
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.
Haematologica
; 99(9): e162-4, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24972772
4.
Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.
Clin Cancer Res
; 16(3): 835-47, 2010 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20086003
5.
NF1 inactivation in adult acute myelogenous leukemia.
Clin Cancer Res
; 16(16): 4135-47, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20505189
6.
Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma.
J Clin Oncol
; 27(30): 5015-22, 2009 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19738129